Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers
Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers.pdf
[en] Objective: To date, serum free testosterone measurement is considered to be the gold standard for the diagnosis of hypogonadism in elderly males but it is not available to all subjects suspected of a decrease in testicular function. Therefore, we evaluated whether the Androgen Deficiency in Aging Males (ADAM) questionnaire, in its original or in a modified 'quantitative' version (qADAM), could be used as a surrogate to biochemical determinations for the identification of hypogonadism in elderly males. Methods: 5028 men, aged 50-70 years, spontaneously consulting for the assessment of their gonadal function were studied. ADAM and qADAM, allocating a value of 1 point for any positive answer to each of the 10 questions of the ADAM test, were assessed for their ability to discriminate between males with free testosterone levels below or above 70 ng/l. Results: The sensitivity and specificity of the ADAM score were 81% and 21.6% respectively. The use of ADAM resulted in an appropriate classification of our population in normal or hypogonadal subjects in 44.5% of the cases. The area under the receiver operating characteristics (ROC) curve for the qADAM (0.529) revealed a highly marginal interest of this quantitative approach compared with the original scoring system. Conclusions: The ADAM test has a high sensitivity to identify aging males with low free testosterone levels. However, due to its lack of specificity, this test cannot be used as a surrogate to serum free testosterone testing for the identification of androgen deficiency in elderly, community-dwelling males.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Tancredi, Annalisa ; Université de Liège - ULiège > Département des sciences de la santé publique > Ecole de santé publique
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Schleich, FLorence ; Centre Hospitalier Universitaire de Liège - CHU > Frais communs médecine
Pire, G.
Maassen, P.
Luyckx, Françoise ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale
Legros, Jean-Jacques ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Language :
English
Title :
Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers
Ethgen O, Richy F, Gosset C, Hanssens L & Reginster J-Y. Prévention de la vulnérabilité de la personne âgée: un défi démographique. Revue Mé dicale de Liège 2003 58 175-182.
Kalache A. Gender-specific health care in the 21st century: a focus on developing countries. The Aging Male 2002 5 129-138.
Lamberts SWJ. The endocrinology of gonadal involution: menopause and andropause. Annales d'Endocrinologie 2003 64 77-81.
Morley JE. Androgens and aging. Maturitas 2001 38 61-73.
Morales A, Heaton JPW & Carson CC. Andropause: a misnomer for a true clinical entity. Journal of Urology 2000 163 705-712.
Juul A & Skakkebaek NE. Androgens and the ageing male. Human Reproduction Update 2002 8 423-433.
Swerdloff RS & Wang C. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel. The Aging Male 2003 6 207-211.
Von Eckardstein S & Nieschlag E. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study Journal of Andrology 2002 23 419-425.
Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T & Berman N. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group. Journal of Clinical Endocrinology and Metabolism 2000 85 2839-2853.
Behre HM, Von Eckardstein S, Kliesch S & Nieschlag E. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years. Clinical Endocrinology 1999 50 629-635.
Nieschlag E, Buchter D, Von Eckardstein S, Abshagen K, Simoni M & Behre HM. Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men. Clinical Endocrinology 1999 51 757-763.
Swerdloff RS & Wang C. Dihydrotestosterone: a rationale for its use as a non-aromatizable androgen replacement therapeutic agent. Baillieres Clinical Endocrinology and Metabolism 1998 12 501-506.
Behre HM, Kliesch S, Leifke E, Link TM & Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 1997 82 2386-2390.
Wang C, Eyre DR, Clark R, Kleinberg D, Newman C, Iranmanesh A, Veldhuis J, Dudley RE, Berman N, Davidson T, Barstow TJ, Sinow R, Alexander G & Swerdloff RS. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypegonadal men: a clinical research center study Journal of Clinical Endocrinology and Metabolism 1996 81 3654-3662.
Rhoden EL & Morgentaler A. Risk of testosterone-replacement therapy and recommendations for monitoring. New England Journal of Medicine 2004 350 482-492.
Snyder PJ. Hypogonadism in elderly men - what to do until the evidence comes. New England Journal of Medicine 2004 350 440-442.
Morales A & Tenover JL. Androgen deficiency in the aging male: when, who, and how to investigate and treat. Urologic Clinics of North America 2002 29 975-982.
Flynn V & Hellstrom WJG. Androgen deficiency in the aging male: pathophysiology, diagnosis, and treatment alternatives. Current Urology Reports 2001 2 473-479.
Morley JE. Testosterone replacement in older men and women. Journal of Gender Specific Medicine 2001 4 49-53.
Nolten WE. Androgen deficiency in the aging male: when to evaluate and when to treat. Current Urology Reports 2000 1 313-319.
Conway K, Heineman LAJ, Giroudet C, Johannes EJ, Myon E, Taieb C & Raynaud J-P. Harmonized French version of the Aging Males' Symptoms scale. The Aging Male 2003 6 106-109.
Heinemann LAJ, Saad F, Zimmermann T, Novak A, Myon E, Badia X, Potthoff P, T'Sjoen G, Pöllanën P, Goncharow NP, Kim S & Giroudet C. The Aging Males' Symptoms (AMS) scale: update and compilation of international versions. Health and Quality of Life Outcomes 2003 1 15.
Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D & Perry HM. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000 49 1239-1242.
Smith KW, Feldman HA & McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clinical Endocrinology 2000 53 703-711.
Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C & Hummel W. A new aging males symptoms rating scale. The Aging Male 1999 2 105-114.
Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of tree testosterone in serum. Journal of Clininical Endocrinology and Metabolism 1999 84 3666-3672.
Legros J-J & Delhez M. Détection de la déficience androgénique chez l'homme de plus de 50 ans: utilisation d'une version française du test ADAM. Médecine et Hygiène 2002 60 1490-1495.
Vermeulen A. Androgen replacement therapy in the aging male - a critical evaluation. Journal of Clinical Endocrinology and Metabolism 2001 86 2380-2387.
Delhez M, Hansenne M & Legros J-J. Andropause and psychopathology: minor symptoms rather than pathological ones. Psychoneuroendocrinology 2002 28 863-874.
Delhez M, Hansenne M, Luyckx F & Legros J-J. Que penser d'un test ADAM positif en l'absence d'hypogonadisme? Annales d'Endocrinologie 2001 62 177.
Carroll BJ, Feinberg M, Smouse PE, Rawson SG & Greden JF. The Carroll rating scale for depression. I. Development, reliability and validation. British Journal of Psychiatry 1981 138 194-200.
T'Sjoen G, Goemaere S, De Meyere M & Kaufman JM. Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology 2004 29 201-214.
Richy F, Gourlay M, Ross PD, Sen SS, Radican L, De Ceulaer F, Ben Sedrine W, Ethgen O, Bruyere O & Reginster J-Y Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium. Quarterly Journal of Medicine 2004 97 39-46.
